Literature DB >> 10719224

Mutant mice lacking ryanodine receptor type 3 exhibit deficits of contextual fear conditioning and activation of calcium/calmodulin-dependent protein kinase II in the hippocampus.

Y Kouzu1, T Moriya, H Takeshima, T Yoshioka, S Shibata.   

Abstract

As it is known that ryanodine receptor type 3 is expressed in the hippocampus, we examined the contribution of this receptor to contextual fear conditioning behavior and to the activation of Ca(2+)/calmodulin-dependent protein kinase II using mice lacking the receptor. Ryanodine receptor type 3-deficient mice exhibited impairments of performance in the contextual fear conditioning test, passive avoidance test, and Y-maze learning test. Both the activities of Ca(2+)/calmodulin-dependent protein kinase IIbeta and Ca(2+)/calmodulin-dependent protein kinase IIalpha were significantly increased in the experimental group compared to the control group in the hippocampus, but not in the cingulate cortex on the testing day 24 h after contextual fear training. However, the activities of Ca(2+)/calmodulin-dependent protein kinase IIbeta and alpha were almost the same in the experimental and control groups in the hippocampus on the training day. Ryanodine receptor type 3-deficient mice did not show the increment of Ca(2+)/calmodulin-dependent protein kinase IIbeta and alpha activities in the hippocampus on the testing day. In addition, these mutant mice showed the reduction of fear response in the elevated plus-maze test. The present results suggest that calcium-induced calcium release through the activation of ryanodine receptor type 3 in the hippocampus is important to the expression of the performance of contextual learning through the elevation of Ca(2+)/calmodulin-dependent protein kinase IIbeta and alpha activities.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10719224     DOI: 10.1016/s0169-328x(99)00344-7

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  22 in total

1.  Involvement of ryanodine receptors in neurotrophin-induced hippocampal synaptic plasticity and spatial memory formation.

Authors:  Tatiana Adasme; Paola Haeger; Andrea C Paula-Lima; Italo Espinoza; M Mercedes Casas-Alarcón; M Angélica Carrasco; Cecilia Hidalgo
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

2.  Functional uncoupling between Ca2+ release and afterhyperpolarization in mutant hippocampal neurons lacking junctophilins.

Authors:  Shigeki Moriguchi; Miyuki Nishi; Shinji Komazaki; Hiroyuki Sakagami; Taisuke Miyazaki; Haruko Masumiya; Shin-Ya Saito; Masahiko Watanabe; Hisatake Kondo; Hiromu Yawo; Kohji Fukunaga; Hiroshi Takeshima
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-29       Impact factor: 11.205

Review 3.  Ryanodine receptor studies using genetically engineered mice.

Authors:  Alexander Kushnir; Matthew J Betzenhauser; Andrew R Marks
Journal:  FEBS Lett       Date:  2010-03-07       Impact factor: 4.124

4.  Ryanodine receptor type 3 does not contribute to contractions in the mouse myometrium regardless of pregnancy.

Authors:  Katsuhito Matsuki; Masashi Takemoto; Yoshiaki Suzuki; Hisao Yamamura; Susumu Ohya; Hiroshi Takeshima; Yuji Imaizumi
Journal:  Pflugers Arch       Date:  2016-11-20       Impact factor: 3.657

5.  Genomewide linkage analysis in Costa Rican families implicates chromosome 15q14 as a candidate region for OCD.

Authors:  Jessica Ross; Judith Badner; Helena Garrido; Brooke Sheppard; Denise A Chavira; Marco Grados; Jonathan M Woo; Pamela Doo; Paula Umaña; Eduardo Fournier; Sarah Shaw Murray; Carol A Mathews
Journal:  Hum Genet       Date:  2011-06-21       Impact factor: 4.132

Review 6.  Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Chuan-Yun Li; Carlo Contoreggi; Judith Hess; Daniel Naiman; Qing-Rong Liu
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

Review 7.  Minding the calcium store: Ryanodine receptor activation as a convergent mechanism of PCB toxicity.

Authors:  Isaac N Pessah; Gennady Cherednichenko; Pamela J Lein
Journal:  Pharmacol Ther       Date:  2009-11-25       Impact factor: 12.310

8.  Different involvement of type 1, 2, and 3 ryanodine receptors in memory processes.

Authors:  Nicoletta Galeotti; Alessandro Quattrone; Elisa Vivoli; Monica Norcini; Alessandro Bartolini; Carla Ghelardini
Journal:  Learn Mem       Date:  2008-04-25       Impact factor: 2.460

9.  Comprehensive behavioral phenotyping of ryanodine receptor type 3 (RyR3) knockout mice: decreased social contact duration in two social interaction tests.

Authors:  Naoki Matsuo; Koichi Tanda; Kazuo Nakanishi; Nobuyuki Yamasaki; Keiko Toyama; Keizo Takao; Hiroshi Takeshima; Tsuyoshi Miyakawa
Journal:  Front Behav Neurosci       Date:  2009-05-07       Impact factor: 3.558

10.  Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy.

Authors:  Hila Ben-Yehuda; Michal Arad; Javier María Peralta Ramos; Efrat Sharon; Giulia Castellani; Shir Ferrera; Liora Cahalon; Sarah Phoebeluc Colaiuta; Tomer-Meir Salame; Michal Schwartz
Journal:  Mol Neurodegener       Date:  2021-06-25       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.